MedTrace Logo

Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression

NCT00641108 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-04-16

Study results available
· View outcomes & findings →

Summary

This study will examine changes in brain serotonin activity in people with depression before and after they receive cognitive behavioral therapy.

Conditions

Interventions

DRUG

ADAM SPECT plus Cognitive Therapy

DRUG

ADAM SPECT plus No Therapy

Sponsors & Collaborators

Principal Investigators

  • Robert J. DeRubeis, PhD · University of Pennsylvania

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641108 on ClinicalTrials.gov